Number of times cited according to CrossRef:

Tamsin Ford, Transitional care for young adults with ADHD: transforming potential upheaval into smooth progression, Epidemiology and Psychiatric Sciences, 10.1017/S2045796019000817, 29,

Jonathan Posner, Guilherme V Polanczyk, Edmund Sonuga-Barke, Attention-deficit hyperactivity disorder, The Lancet, 10.1016/S0140-6736(19)33004-1,

Maria Emilsson, Per Gustafsson, Gisela Öhnström, Ina Marteinsdottir, Impact of personality on adherence to and beliefs about ADHD medication, and perceptions of ADHD in adolescents, BMC Psychiatry, 10.1186/s12888-020-02543-x, 20, 1,

Ramon R. Contrucci, Tibor M. Brunt, Funda Inan, Eric J. F. Franssen, Laura Hondebrink, Synthetic Cathinones and Their Potential Interactions with Prescription Drugs, Therapeutic Drug Monitoring, 10.1097/FTD.0000000000000682, 42, 1, (75-82),

Heidi Boland, Maura DiSalvo, Ronna Fried, K. Yvonne Woodworth, Timothy Wilens, Stephen V. Faraone, Joseph Biederman, A literature review and meta-analysis on the effects of ADHD medications on functional outcomes, Journal of Psychiatric Research, 10.1016/j.jpsychires.2020.01.006,

Geon Ho Bahn, Young Sik Lee, Hanik K. Yoo, Eui-Jung Kim, Subin Park, Doug Hyun Han, Minha Hong, Bongseog Kim, Soyoung Irene Lee, Soo Young Bhang, Seung Yup Lee, Jin Pyo Hong, Yoo-Sook Joung, Development of the Korean Practice Parameter for Adult Attention-Deficit/Hyperactivity Disorder, Journal of the Korean Academy of Child and Adolescent Psychiatry, 10.5765/jkacap.190030, 31, 1, (5-25),

Stefano Pallanti, Luana Salerno, Stefano Pallanti, Luana Salerno, Adult ADHD: Future Directions for Practice and Research, The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders, 10.1007/978-3-030-39051-8, (347-371),

Stefano Pallanti, Luana Salerno, Stefano Pallanti, Luana Salerno, Adult ADHD in Psychiatric Conditions, The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders, 10.1007/978-3-030-39051-8, (87-95),

Luana Salerno, Sonia Gaur, Giacomo Grassi, Stefano Pallanti, Neuromodulation in Attention-Deficit/Hyperactivity Disorder: Toward a Precision Psychiatry Approach, Non Invasive Brain Stimulation in Psychiatry and Clinical Neurosciences, 10.1007/978-3-030-43356-7, (107-122),

Ebba Du Rietz, Andreas Jangmo, Ralf Kuja‐Halkola, Zheng Chang, Brian M. D'Onofrio, Ewa Ahnemark, Tamara Werner‐Kiechle, Henrik Larsson, Trajectories of healthcare utilization and costs of psychiatric and somatic multimorbidity in adults with childhood ADHD: a prospective register‐based study, Journal of Child Psychology and Psychiatry, 10.1111/jcpp.13206, 61, 9, (959-968),

Yanli Zhang‐James, Qi Chen, Ralf Kuja‐Halkola, Paul Lichtenstein, Henrik Larsson, Stephen V. Faraone, Machine‐Learning prediction of comorbid substance use disorders in ADHD youth using Swedish registry data, Journal of Child Psychology and Psychiatry, 10.1111/jcpp.13226, 0, 0,

Alexandra P. Lam, Sebastian Moeller, Christine Speitling, Martin C. Lam, Alexandra Philipsen, Helge H. O. Müller, Consumption of Synthetic Cannabinoids in Adult Attention-Deficit/Hyperactivity Disorder: a Pilot Study, International Journal of Mental Health and Addiction, 10.1007/s11469-020-00248-6,

Muhammad Umair Khan, Parisa Aslani, Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD, Health Expectations, 10.1111/hex.13031, 0, 0,

Chi Liao, ADHD Symptoms and Financial Distress*, Review of Finance, 10.1093/rof/rfaa013,

Alexander Häge, Sarah Hohmann, Sabina Millenet, Tobias Banaschewski, Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im Kindes- und JugendalterAttention deficit hyperactivity disorder in childhood and adolescence, Der Nervenarzt, 10.1007/s00115-020-00904-1,

W. Retz, P. Retz-Junginger, S. Davydenko, M. Rösler, Medikamentöse Therapie der Aufmerksamkeitsdefizit‑/Hyperaktivitätsstörung im ErwachsenenalterPharmacotherapy of attention deficit hyperactivity disorder in adults, Der Nervenarzt, 10.1007/s00115-020-00891-3,

Patrick D. Quinn, Kimberly L. Fine, Martin E. Rickert, Ayesha C. Sujan, Katja Boersma, Zheng Chang, Johan Franck, Paul Lichtenstein, Henrik Larsson, Brian M. D’Onofrio, Association of Opioid Prescription Initiation During Adolescence and Young Adulthood With Subsequent Substance-Related Morbidity, JAMA Pediatrics, 10.1001/jamapediatrics.2020.2539,

Laura Ghirardi, Qi Chen, Zheng Chang, Ralf Kuja‐Halkola, Charlotte Skoglund, Patrick D. Quinn, Brian M. D'Onofrio, Henrik Larsson, Use of medication for attention‐deficit/hyperactivity disorder and risk of unintentional injuries in children and adolescents with co‐occurring neurodevelopmental disorders, Journal of Child Psychology and Psychiatry, 10.1111/jcpp.13136, 61, 2, (140-147),

J.J.S. Kooij, D. Bijlenga, L. Salerno, R. Jaeschke, I. Bitter, J. Balázs, J. Thome, G. Dom, S. Kasper, C. Nunes Filipe, S. Stes, P. Mohr, S. Leppämäki, M. Casas Brugué, J. Bobes, J.M. Mccarthy, V. Richarte, A. Kjems Philipsen, A. Pehlivanidis, A. Niemela, B. Styr, B. Semerci, B. Bolea-Alamanac, D. Edvinsson, D. Baeyens, D. Wynchank, E. Sobanski, A. Philipsen, F. McNicholas, H. Caci, I. Mihailescu, I. Manor, I. Dobrescu, J. Krause, J. Fayyad, J.A. Ramos-Quiroga, K. Foeken, F. Rad, M. Adamou, M. Ohlmeier, M. Fitzgerald, M. Gill, M. Lensing, N. Motavalli Mukaddes, P. Brudkiewicz, P. Gustafsson, P. Tani, P. Oswald, P.J. Carpentier, P. De Rossi, R. Delorme, S. Markovska Simoska, S. Pallanti, S. Young, S. Bejerot, T. Lehtonen, J. Kustow, U. Müller-Sedgwick, T. Hirvikoski, V. Pironti, Y. Ginsberg, Z. Félegeházy, M.P. Garcia-Portilla, P. Asherson, Updated European Consensus Statement on diagnosis and treatment of adult ADHD, European Psychiatry, 10.1016/j.eurpsy.2018.11.001, 56, (14-34),

Christina Mohr-Jensen, Charlotte Müller Bisgaard, Søren Kjærsgaard Boldsen, Hans-Christoph Steinhausen, Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence and the Risk of Crime in Young Adulthood in a Danish Nationwide Study, Journal of the American Academy of Child & Adolescent Psychiatry, 10.1016/j.jaac.2018.11.016,

S. Weibel, O. Menard, A. Ionita, M. Boumendjel, C. Cabelguen, C. Kraemer, J.-A. Micoulaud-Franchi, S. Bioulac, N. Perroud, A. Sauvaget, L. Carton, M. Gachet, R. Lopez, Practical considerations for the evaluation and management of Attention Deficit Hyperactivity Disorder (ADHD) in adults, L'Encéphale, 10.1016/j.encep.2019.06.005,

Helga Krinzinger, Charlotte L Hall, Madeleine J Groom, Mohammed T Ansari, Tobias Banaschewski, Jan K Buitelaar, Sara Carucci, David Coghill, Marina Danckaerts, Ralf W Dittmann, Bruno Falissard, Peter Garas, Sarah K Inglis, Hanna Kovshoff, Puja Kochhar, Suzanne McCarthy, Peter Nagy, Antje Neubert, Samantha Roberts, Kapil Sayal, Edmund Sonuga-Barke, Ian C K Wong, Jun Xia, Alexander Zuddas, Chris Hollis, Kerstin Konrad, Elizabeth B Liddle, Neurological and psychiatric adverse effects of long-term methylphenidate treatment in ADHD: A map of the current evidence, Neuroscience & Biobehavioral Reviews, 10.1016/j.neubiorev.2019.09.023,

Berit Libutzki, Saskia Ludwig, Melanie May, Rasmus Højbjerg Jacobsen, Andreas Reif, Catharina A. Hartman, Direct medical costs of ADHD and its comorbid conditions on basis of a claims data analysis, European Psychiatry, 10.1016/j.eurpsy.2019.01.019, 58, (38-44),

Kamala D. Via, Preventing the Next Epidemic: Prescribed Stimulant Abuse, The Journal for Nurse Practitioners, 10.1016/j.nurpra.2018.12.012,

Amber D. Hunt, David W. Dunn, Hillary S. Blake, Jennifer Downs, Treatment Resistance in Attention-Deficit/Hyperactivity Disorder, Treatment Resistance in Psychiatry, 10.1007/978-981-10-4358-1, (215-235),

Joseph Biederman, Maura DiSalvo, Ronna Fried, K. Yvonne Woodworth, Itai Biederman, Stephen V. Faraone, Quantifying the Protective Effects of Stimulants on Functional Outcomes in Attention-Deficit/Hyperactivity Disorder: A Focus on Number Needed to Treat Statistic and Sex Effects, Journal of Adolescent Health, 10.1016/j.jadohealth.2019.05.015,

Zheng Chang, Laura Ghirardi, Patrick D. Quinn, Philip Asherson, Brian M. D’Onofrio, Henrik Larsson, Risks and benefits of ADHD medication on behavioral and neuropsychiatric outcomes: a qualitative review of pharmacoepidemiology studies using linked prescription databases, Biological Psychiatry, 10.1016/j.biopsych.2019.04.009,

Mauricio Arcos-Burgos, Jorge I. Vélez, Ariel F. Martinez, Marta Ribasés, Josep A. Ramos-Quiroga, Cristina Sánchez-Mora, Vanesa Richarte, Carlos Roncero, Bru Cormand, Noelia Fernández-Castillo, Miguel Casas, Francisco Lopera, David A. Pineda, Juan D. Palacio, Johan E. Acosta-López, Martha L. Cervantes-Henriquez, Manuel G. Sánchez-Rojas, Pedro J. Puentes-Rozo, Brooke S. G. Molina, Margaret T. Boden, Deeann Wallis, Brett Lidbury, Saul Newman, Simon Easteal, James Swanson, Hardip Patel, Nora Volkow, Maria T. Acosta, Francisco X. Castellanos, Jose de Leon, Claudio A. Mastronardi, Maximilian Muenke, ADGRL3 (LPHN3) variants predict substance use disorder, Translational Psychiatry, 10.1038/s41398-019-0396-7, 9, 1,

Fang-Ju Tsai, Wan-Ling Tseng, Li-Kuang Yang, Susan Shur-Fen Gau, Psychiatric comorbid patterns in adults with attention-deficit hyperactivity disorder: Treatment effect and subtypes, PLOS ONE, 10.1371/journal.pone.0211873, 14, 2, (e0211873),

Shihua Sun, Ralf Kuja-Halkola, Stephen V. Faraone, Brian M. D’Onofrio, Søren Dalsgaard, Zheng Chang, Henrik Larsson, Association of Psychiatric Comorbidity With the Risk of Premature Death Among Children and Adults With Attention-Deficit/Hyperactivity Disorder, JAMA Psychiatry, 10.1001/jamapsychiatry.2019.1944,

Maria Emilsson, Ina Berndtsson, Per A. Gustafsson, Robert Horne, Ina Marteinsdottir, Reliability and validation of Swedish translation of Beliefs about Medication Specific (BMQ-Specific) and Brief Illness Perception Questionnaire (B-IPQ) for use in adolescents with attention-deficit hyperactivity disorder, Nordic Journal of Psychiatry, 10.1080/08039488.2019.1674376, (1-7),

Mathias Luderer, Falk Kiefer, Andreas Reif, Franz Moggi, ADHS bei erwachsenen Patienten mit SubstanzkonsumstörungenADHD in adult patients with substance use disorders, Der Nervenarzt, 10.1007/s00115-019-0779-2,

Kelsey K. Wiggs, Zheng Chang, Patrick D. Quinn, Kwan Hur, Robert Gibbons, David Dunn, Isabell Brikell, Henrik Larsson, Brian M. D'Onofrio, Attention-deficit/hyperactivity disorder medication and seizures, Neurology, 10.1212/WNL.0000000000005213, 90, 13, (e1104-e1110),

Barbara Franke, Giorgia Michelini, Philip Asherson, Tobias Banaschewski, Andrea Bilbow, Jan K. Buitelaar, Bru Cormand, Stephen V. Faraone, Ylva Ginsberg, Jan Haavik, Jonna Kuntsi, Henrik Larsson, Klaus-Peter Lesch, J. Antoni Ramos-Quiroga, János M. Réthelyi, Marta Ribases, Andreas Reif, Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan, European Neuropsychopharmacology, 10.1016/j.euroneuro.2018.08.001, 28, 10, (1059-1088),

L. Zimmer, P. Fourneret, Tout ce que vous devez connaître sur le méthylphénidate (sans oser le demander…), Archives de Pédiatrie, 10.1016/j.arcped.2018.01.002, 25, 3, (229-235),

Timothy E. Wilens, Tamar Arit Kaminski, The Co-Occurrence of ADHD and Substance Use Disorders, Psychiatric Annals, 10.3928/00485713-20180613-01, 47, 7, (328-332),

Robert Eme, ADHD and Risky Substance Use in Male Adolescents, Child and Adolescent Psychopharmacology News, 10.1521/capn.2018.22.3.1, 22, 3, (1-8,10),

Tom Nicholson, Outcomes of untreated attention deficit hyperactivity disorder and the mental health nurse, British Journal of Mental Health Nursing, 10.12968/bjmh.2018.7.3.113, 7, 3, (113-118),

Timothy E. Wilens, Benjamin M. Isenberg, Tamar A. Kaminski, Rachael M. Lyons, Javier Quintero, Attention-Deficit/Hyperactivity Disorder and Transitional Aged Youth, Current Psychiatry Reports, 10.1007/s11920-018-0968-x, 20, 11,

Melinda Sandler Morrill, Special Education Financing and ADHD Medications: A Bitter Pill to Swallow, Journal of Policy Analysis and Management, 10.1002/pam.22055, 37, 2, (384-402),

Suzanne McCarthy, Antje Neubert, Kenneth K. C. Man, Tobias Banaschewski, Jan Buitelaar, Sara Carucci, David Coghill, Marina Danckaerts, Bruno Falissard, Peter Garas, Alexander Häge, Chris Hollis, Sarah Inglis, Hanna Kovshoff, Elizabeth Liddle, Konstantin Mechler, Peter Nagy, Eric Rosenthal, Robert Schlack, Edmund Sonuga-Barke, Alessandro Zuddas, Ian C. K. Wong, Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS), BMC Psychiatry, 10.1186/s12888-018-1884-7, 18, 1,

Benedetto Vitiello, Chiara Davico, Twenty years of progress in paediatric psychopharmacology: accomplishments and unmet needs, Evidence Based Mental Health, 10.1136/ebmental-2018-300040, 21, 4, (e10-e10),

Thomas W. Wojciechowski, ADHD Presentation and Alcohol Use Among Juvenile Offenders: A Group-Based Trajectory Modeling Approach, Journal of Child & Adolescent Substance Abuse, 10.1080/1067828X.2017.1411304, 27, 2, (86-96),

Thomas W. Wojciechowski, Trajectories of Binge Drinking Behavior across Adolescence among Juvenile Offenders and the Role of ADHD for Predicting Development, Deviant Behavior, 10.1080/01639625.2017.1335517, 39, 6, (807-821),

David R. Coghill, Tobias Banaschewski, César Soutullo, Matthew G. Cottingham, Alessandro Zuddas, Systematic review of quality of life and functional outcomes in randomized placebo-controlled studies of medications for attention-deficit/hyperactivity disorder, European Child & Adolescent Psychiatry, 10.1007/s00787-017-0986-y, 26, 11, (1283-1307),

Swapna Deshpande, Britta Ostermeyer, Akshay Lokhande, Humaira Abid, Asim A. Shah, Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?, Psychiatric Annals, 10.3928/00485713-20170515-01, 47, 6, (315-321),

Manfred Gerlach, Tobias Banaschewski, David Coghill, Luis A. Rohde, Marcel Romanos, What are the benefits of methylphenidate as a treatment for children and adolescents with attention-deficit/hyperactivity disorder?, ADHD Attention Deficit and Hyperactivity Disorders, 10.1007/s12402-017-0220-2, 9, 1, (1-3),

Robert Eme, ADHD and Risky Substance Use in Male Adolescents, Child and Adolescent Psychopharmacology News, 10.1521/capn.2017.22.3.1, 22, 3, (1-8,10),

Ebba Du Rietz, Ralf Kuja-Halkola, Isabell Brikell, Andreas Jangmo, Amir Sariaslan, Paul Lichtenstein, Jonna Kuntsi, Henrik Larsson, Predictive validity of parent- and self-rated ADHD symptoms in adolescence on adverse socioeconomic and health outcomes, European Child & Adolescent Psychiatry, 10.1007/s00787-017-0957-3, 26, 7, (857-867),

Mirjam Just, Anna Kaiser, Wolfgang Retz, Michael Rösler, Tobias Banaschewski, Sarah Hohmann, Sabina Millenet, Aufmerksamkeitsdefizit-/Hyperaktivitätsstörungen – Risiko für Delinquenz im Jugend- und Erwachsenenalter?Attention deficit hyperactivity disorder – Risk of delinquency in adolescence and adulthood?, Forensische Psychiatrie, Psychologie, Kriminologie, 10.1007/s11757-017-0422-7, 11, 2, (96-102),

Maria Emilsson, Per A. Gustafsson, Gisela Öhnström, Ina Marteinsdottir, Beliefs regarding medication and side effects influence treatment adherence in adolescents with attention deficit hyperactivity disorder, European Child & Adolescent Psychiatry, 10.1007/s00787-016-0919-1, 26, 5, (559-571),

Agnieszka Butwicka, Niklas Långström, Henrik Larsson, Sebastian Lundström, Eva Serlachius, Catarina Almqvist, Louise Frisén, Paul Lichtenstein, Increased Risk for Substance Use-Related Problems in Autism Spectrum Disorders: A Population-Based Cohort Study, Journal of Autism and Developmental Disorders, 10.1007/s10803-016-2914-2, 47, 1, (80-89),

A.C. Castagnini, L. Foldager, E. Caffo, P.H. Thomsen, Early-adult outcome of child and adolescent mental disorders as evidenced by a national-based case register survey, European Psychiatry, 10.1016/j.eurpsy.2016.04.005, 38, (45-50),

B. Bihlar Muld, J. Jokinen, S. Bölte, T. Hirvikoski, Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study, ADHD Attention Deficit and Hyperactivity Disorders, 10.1007/s12402-016-0195-4, 8, 3, (159-172),

Zheng Chang, Brian M. D’Onofrio, Patrick D. Quinn, Paul Lichtenstein, Henrik Larsson, Medication for Attention-Deficit/Hyperactivity Disorder and Risk for Depression: A Nationwide Longitudinal Cohort Study, Biological Psychiatry, 10.1016/j.biopsych.2016.02.018, 80, 12, (916-922),

Philip Asherson, Jan Buitelaar, Stephen V Faraone, Luis A Rohde, Adult attention-deficit hyperactivity disorder: key conceptual issues, The Lancet Psychiatry, 10.1016/S2215-0366(16)30032-3, 3, 6, (568-578),

Sean Esteban McCabe, Kara Dickinson, Brady T. West, Timothy E. Wilens, Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study, Journal of the American Academy of Child & Adolescent Psychiatry, 10.1016/j.jaac.2016.03.011, 55, 6, (479-486),

Rose Cairns, Benjamin Daniels, Danielle A Wood, Jonathan Brett, ADHD medication overdose and misuse: the NSW Poisons Information Centre experience, 2004–2014, Medical Journal of Australia, 10.5694/mja15.00791, 204, 4, (154-154),

Predrag Petrovic, F. Xavier Castellanos, Top-Down Dysregulation—From ADHD to Emotional Instability, Frontiers in Behavioral Neuroscience, 10.3389/fnbeh.2016.00070, 10,

Kirsten Rasmussen, Tom Palmstierna, Sten Levander, Differences in Psychiatric Problems and Criminality Between Individuals Treated With Central Stimulants Before and After Adulthood, Journal of Attention Disorders, 10.1177/1087054715571740, 23, 2, (173-180),

Adrian L. Lopresti, Oxidative and nitrosative stress in ADHD: possible causes and the potential of antioxidant-targeted therapies, ADHD Attention Deficit and Hyperactivity Disorders, 10.1007/s12402-015-0170-5, 7, 4, (237-247),

Stephanie G. Craig, Gregory Davies, Larry Schibuk, Margaret D. Weiss, Lily Hechtman, Long-Term Effects of Stimulant Treatment for ADHD: What Can We Tell Our Patients?, Current Developmental Disorders Reports, 10.1007/s40474-015-0039-5, 2, 1, (1-9),

Argelinda Baroni, F Xavier Castellanos, Stimulants, cognition and ADHD, Current Opinion in Behavioral Sciences, 10.1016/j.cobeha.2015.04.010, 4, (109-114),

Ylva Ginsberg, Niklas Långström, Henrik Larsson, Nils Lindefors, Long-Term Treatment Outcome in Adult Male Prisoners With Attention-Deficit/Hyperactivity Disorder, Journal of Clinical Psychopharmacology, 10.1097/JCP.0000000000000395, 35, 5, (535-543),

Thomas Villemonteix, Stéphane A. De Brito, Martin Kavec, Danielle Balériaux, Thierry Metens, Hichem Slama, Simon Baijot, Alison Mary, Philippe Peigneux, Isabelle Massat, Grey matter volumes in treatment naïve vs. chronically treated children with attention deficit/hyperactivity disorder: a combined approach, European Neuropsychopharmacology, 10.1016/j.euroneuro.2015.04.015, 25, 8, (1118-1127),

Ashley C. Littleton, Julianne D. Schmidt, Johna K. Register-Mihalik, Gerard A. Gioia, Kelly M. Waicus, Jason P. Mihalik, Kevin M. Guskiewicz, Effects of Attention Deficit Hyperactivity Disorder and Stimulant Medication on Concussion Symptom Reporting and Computerized Neurocognitive Test Performance, Archives of Clinical Neuropsychology, 10.1093/arclin/acv043, 30, 7, (683-693),

Jeffrey H Newcorn, Iliyan Ivanov, Anil Chacko, Recent Progress in Psychosocial and Psychopharmacologic Treatments for ADHD, Current Treatment Options in Psychiatry, 10.1007/s40501-015-0030-0, 2, 1, (14-27),

Charlotte Skoglund, Qi Chen, Johan Franck, Paul Lichtenstein, Henrik Larsson, Attention-Deficit/Hyperactivity Disorder and Risk for Substance Use Disorders in Relatives, Biological Psychiatry, 10.1016/j.biopsych.2014.10.006, 77, 10, (880-886),

Robert Eme, Sex Difference in Attention-Deficit/Hyperactivity Disorder Contributes to the Sex Difference in Crime and Antisocial Behavior, Violence and Gender, 10.1089/vio.2014.0025, 2, 2, (101-106),

Samira Groß, Alexandra Philipsen, Konzeptualisierung der Psychotherapie bei ADHS und Sucht, SUCHT, 10.1024/0939-5911.a000387, 61, 5, (311-318),